Capital Analysts LLC’s Capricor Therapeutics CAPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$10.2K Buy
+1,076
New +$11.9K ﹤0.01% 1295

Other funds holding CAPR

Capital Analysts LLC's CAPR Position: Q3 2026 in Review

Capital Analysts LLC opened a new position in Capricor Therapeutics (CAPR) in Q3 2026: 1,076 shares worth $10.2K. The stake represents ﹤0.01% of the portfolio and ranks #1295 among its holdings.

157 funds tracked by Wall St. Rank hold CAPR as of Q3 2026.

  • Capital Analysts LLC held 1,076 shares of Capricor Therapeutics worth $10.2K as of Q3 2026.
  • Capricor Therapeutics was a new Capital Analysts LLC position in Q3 2026.
  • Capricor Therapeutics made up ﹤0.01% of Capital Analysts LLC's portfolio in Q3 2026, its #1295 holding.
  • 157 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q3 2026.

Based on Capital Analysts LLC's 13F filing for Q3 2026, filed 13 Nov 2026.